Drug companies expected to get more leeway in communicating with patients in Europe

Authors
Publication date
Publisher
'BMJ'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      Last time updated on 03/01/2020